08 Sep Completion of acquisition of Yourgene Health plc and Board appointments

Posted at 12:07h in Board, Novacyt Group, Uncategorized by

Acquisition adds scale and diversification to create a stronger global diagnostics business, with a complementary suite of genomic technologies and services

Paris, France and Eastleigh, UK – 8 September 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the completion of the acquisition by Novacyt UK Holdings Limited (“Novacyt UK“), a wholly-owned subsidiary of Novacyt, of the entire share capital of Yourgene Health plc (“Yourgene”), an international molecular diagnostic group (the “Acquisition”). The Acquisition has been implemented by way of a scheme of arrangement between Yourgene and its shareholders under Part 26 of the UK Companies Act 2006 (the “Scheme“).

Completion of acquisition of Yourgene Health plc and Board appointments